Literature DB >> 21388991

Beyond dyspnoea as an endpoint in acute heart failure trials.

Mihai Gheorghiade, Frank Ruschitzka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21388991     DOI： 10.1093/eurheartj/ehr044

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

Review 1.  Drugs' development in acute heart failure: what went wrong?

Authors:  Vincenzo Teneggi; Nithy Sivakumar; Deborah Chen; Alex Matter
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 2.  The disconnect between phase II and phase III trials of drugs for heart failure.

Authors:  Muthiah Vaduganathan; Stephen J Greene; Andrew P Ambrosy; Mihai Gheorghiade; Javed Butler
Journal:  Nat Rev Cardiol       Date:  2013-01-08       Impact factor: 32.419

3.  Assessment of dyspnea early in acute heart failure: patient characteristics and response differences between likert and visual analog scales.

Authors:  Peter S Pang; Sean P Collins; Kori Sauser; Adin-Cristian Andrei; Alan B Storrow; Judd E Hollander; Miguel Tavares; Jindrich Spinar; Cezar Macarie; Dimitar Raev; Richard Nowak; Mihai Gheorghiade; Alexandre Mebazaa
Journal:  Acad Emerg Med       Date:  2014-06       Impact factor: 3.451
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.